![Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms | The Royal Society of Canada Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms | The Royal Society of Canada](https://rsc-src.ca/sites/default/files/file-20210527-21-1ne4g5u%20%281%29.jpeg)
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms | The Royal Society of Canada
![Booster Shots and Additional Doses for COVID-19 Vaccines — What You Need to Know | Johns Hopkins Medicine Booster Shots and Additional Doses for COVID-19 Vaccines — What You Need to Know | Johns Hopkins Medicine](https://www.hopkinsmedicine.org/-/media/images/health/1_-conditions/coronavirus/booster-hero.jpg?h=500&iar=0&mh=500&mw=1300&w=1297&hash=347BF4C0B6A9B79B1BD52AF5F53E5AEC)
Booster Shots and Additional Doses for COVID-19 Vaccines — What You Need to Know | Johns Hopkins Medicine
![India likely to allow smaller gap between AstraZeneca COVID vaccine doses sold privately - sources | Reuters India likely to allow smaller gap between AstraZeneca COVID vaccine doses sold privately - sources | Reuters](https://cloudfront-us-east-2.images.arcpublishing.com/reuters/WJRZI5ONYBPZ3GFZMJ7RA6NLVI.jpg)
India likely to allow smaller gap between AstraZeneca COVID vaccine doses sold privately - sources | Reuters
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x627.jpg?_=39294)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![OCHD COVID-19 CLINICS PROVIDING ADDITIONAL DOSE FOR MODERATELY OR SEVERELY IMMUNOCOMPROMISED INDIVIDUALS – Ocean County Health Department OCHD COVID-19 CLINICS PROVIDING ADDITIONAL DOSE FOR MODERATELY OR SEVERELY IMMUNOCOMPROMISED INDIVIDUALS – Ocean County Health Department](https://www.ochd.org/wp-content/uploads/2021/08/vaccine-5926664_1920-1.jpg)
OCHD COVID-19 CLINICS PROVIDING ADDITIONAL DOSE FOR MODERATELY OR SEVERELY IMMUNOCOMPROMISED INDIVIDUALS – Ocean County Health Department
![New Study Finds Children Who Had Multisystem Inflammatory Syndrome Had No Serious Complications from COVID19 Vaccine | Intermountain Healthcare New Study Finds Children Who Had Multisystem Inflammatory Syndrome Had No Serious Complications from COVID19 Vaccine | Intermountain Healthcare](https://intermountainhealthcare.org/-/media/images/modules/news/covid/covidvaccine.jpg?mw=1600)
New Study Finds Children Who Had Multisystem Inflammatory Syndrome Had No Serious Complications from COVID19 Vaccine | Intermountain Healthcare
![DPH PUTTING HOLD ON THE USE OF THE J&J ONE-DOSE COVID-19 VACCINE | WITN Channel 22 Wilmington, Delaware DPH PUTTING HOLD ON THE USE OF THE J&J ONE-DOSE COVID-19 VACCINE | WITN Channel 22 Wilmington, Delaware](https://www.witn22.org/wp-content/uploads/2021/04/040221-Johnson-Johnson-Jansen-Covid19-vaccine-SS-306-1024x683.jpg)